Evaluation of the Safety of Deutetrabenazine at Higher Doses to Treat Chorea in Huntington's Disease

被引：0
|
作者：
Frank, S. [1 ]
Vaughan, C. [1 ]
Stamler, D. [1 ]
Oakes, D. [1 ]
Davis, M. [1 ]
Gross, N. [1 ]
Gordon, M. [1 ]
Savola, J. M. [1 ]
Wieman, M. [1 ]
Eberly, S. [1 ]
Kayson, E. [1 ]
Whaley, J. [1 ]
Goldstein, J. [1 ]
Testa, C. [1 ]
机构：
[1] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA
来源：
MOVEMENT DISORDERS | 2020年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
246
引用
收藏
页码：S98 / S98
页数：1
相关论文
共 50 条
  • [31] Cumulative Real-World Experience with Deutetrabenazine for Huntington's Disease Chorea at a Single Center of Excellence in the US
    Curtis, K.
    Denson, B.
    Sung, V.
    MOVEMENT DISORDERS, 2021, 36 : S96 - S97
  • [32] Long-Term Efficacy and Safety of Deutetrabenazine for Chorea in Huntington's Disease: Results From the ARC-HD Open-Label Study
    Frank, Samuel
    Testa, Claudia M.
    Stamler, David
    Kayson, Elise
    Oakes, David
    Vaughan, Christina
    Goldstein, Jody
    Whaley, Jacquelyn
    Davis, Matthew D.
    Gordon, Mark Forrest
    Savolay, Juha-Matti
    NEUROTHERAPEUTICS, 2020, 17 (SUPPL 1) : 27 - 28
  • [33] Managing chorea in Huntington's disease
    Vaou, Okeanis
    Frank, Samuel
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2011, 1 (04) : 295 - 306
  • [34] Chorea not due to Huntington's disease
    Gordji, A
    SEMAINE DES HOPITAUX, 1997, 73 (15-16): : 460 - 464
  • [35] Awareness of Chorea in Huntington's Disease
    Hergert, Danielle C.
    Sanchez-Ramos, Juan
    Cimino, Cynthia R.
    JOURNAL OF HUNTINGTONS DISEASE, 2020, 9 (01) : 99 - 103
  • [36] Indirect treatment comparison of valbenazine with deutetrabenazine for improvement in total maximal chorea score in Huntington disease
    Mehanna, R.
    Stimming, E. Furr
    Haubenberger, D.
    Klepitskaya, O.
    Aggarwal, S.
    Kumar, S.
    Topaloglu, O.
    Goldstein, J.
    Kayson, E.
    Serbin, M.
    MOVEMENT DISORDERS, 2023, 38 : S396 - S396
  • [37] Tetrabenazine in Huntington's Disease Chorea
    Chitnis, Shilpa
    Karunapuzha, Cherian Abraham
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2009, 1 : 669 - 681
  • [38] Correction: Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease (vol 13,Pg 655-675,2024)
    Frank, Samuel
    Anderson, Karen E.
    Fernandez, Hubert H.
    Hauser, Robert A.
    Claassen, Daniel O.
    Stamler, David
    Factor, Stewart A.
    Jimenez-Shahed, Joohi
    Barkay, Hadas
    Wilhelm, Amanda
    Alexander, Jessica K.
    Chaijale, Nayla
    Barash, Steve
    Savola, Juha-Matti
    Gordon, Mark Forrest
    Chen, Maria
    NEUROLOGY AND THERAPY, 2024, 13 (06) : 1747 - 1749
  • [39] EFFICACY AND SAFETY OF TIAPRIDE FOR CHOREA TREATMENT IN HUNTINGTON'S DISEASE: A SYSTEMATIC REVIEW
    Feleus, Stephanie
    van Schaijk, Malu
    Roos, Raymund A. C.
    de Bot, Susanne
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2021, 92 : A54 - A54
  • [40] DEUTETRABENAZINE: UPDATE ON FIRST TIME USE OF SD-809 IN HUNTINGTON'S DISEASE (FIRST-HD) AND ALTERNATIVE FOR REDUCING CHOREA IN HUNTINGTON'S DISEASE (ARC-HD)
    Testa, Claudia
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A101 - A101
12345